User profiles for Noelle K. LoConte
Noelle LoConteAssociate Professor of Medicine, University of Wisconsin, Madison Verified email at medicine.wisc.edu Cited by 7847 |
[HTML][HTML] Adjuvant chemotherapy for stage II colon cancer with poor prognostic features
ES O'Connor, DY Greenblatt, NK LoConte… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Adjuvant chemotherapy is typically considered for patients with stage II colon cancer
characterized by poor prognostic features, including obstruction, perforation, emergent …
characterized by poor prognostic features, including obstruction, perforation, emergent …
Alcohol and cancer: a statement of the American Society of Clinical Oncology
NK LoConte, AM Brewster, JS Kaur… - Journal of Clinical …, 2018 - ascopubs.org
Alcohol drinking is an established risk factor for several malignancies, and it is a potentially
modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society …
modifiable risk factor for cancer. The Cancer Prevention Committee of the American Society …
Perceived stigma, self-blame, and adjustment among lung, breast and prostate cancer patients
NM Else-Quest, NK LoConte, JH Schiller… - Psychology and …, 2009 - Taylor & Francis
People who suffer from disease have often been stigmatised. The internalisation of stigma
leads to the experience of self-blame. The relationship among stigma, self-blame and …
leads to the experience of self-blame. The relationship among stigma, self-blame and …
[HTML][HTML] Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II …
…, MR Mahoney, JL Kolesar, NK LoConte… - Journal of Clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Biliary cancers overexpress epidermal growth factor receptor (EGFR), and angiogenesis
has been correlated with poor outcome. Erlotinib, an EGFR tyrosine kinase inhibitor, …
has been correlated with poor outcome. Erlotinib, an EGFR tyrosine kinase inhibitor, …
Global epidemiology, prevention, and management of hepatocellular carcinoma
…, P Chinchilla-López, HA Torres, NK LoConte… - American Society of …, 2018 - ascopubs.org
The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …
Readmission after colectomy for cancer predicts one-year mortality
…, SM Weber, ES O'Connor, NK LoConte… - Annals of …, 2010 - journals.lww.com
Objectives: Early hospital readmission is a common and costly problem in the Medicare
population. In 2009, the Centers for Medicaid and Medicare Services began mandating hospital …
population. In 2009, the Centers for Medicaid and Medicare Services began mandating hospital …
Assessment of guilt and shame in patients with non–small-cell lung cancer compared with patients with breast and prostate cancer
PURPOSE Patients with lung cancer might feel more guilt and shame resulting from previous
smoking. This study was designed to determine the levels of guilt and shame among …
smoking. This study was designed to determine the levels of guilt and shame among …
Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic …
…, T Reid, E Borazanci, T Crocenzi, NK LoConte… - Clinical Cancer …, 2019 - AACR
Purpose: Limited options exist for patients with advanced pancreatic cancer progressing
after 1 or more lines of therapy. A phase II study in patients with previously treated metastatic …
after 1 or more lines of therapy. A phase II study in patients with previously treated metastatic …
Predictors of short-term postoperative survival after elective colectomy in colon cancer patients≥ 80 years of age
…, ES O'Connor, DY Greenblatt, NK LoConte… - Annals of surgical …, 2013 - Springer
Background Individuals ≥80 years of age represent an increasing proportion of colon
cancer diagnoses. Selecting these patients for elective surgery is challenging because of …
cancer diagnoses. Selecting these patients for elective surgery is challenging because of …
[HTML][HTML] Esophagogastric cancers: integrating immunotherapy therapy into current practice
Immunotherapy (IO) agents have led to significant improvements in patient outcomes across
many tumor types. There have been great efforts to introduce immune checkpoint inhibitors …
many tumor types. There have been great efforts to introduce immune checkpoint inhibitors …